Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study of Therapeutic Fasting to Reduce Limitations in Physical Well-being and Quality of Life During Endocrine Therapy With Aromatase Inhibitors

NCT06172088 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT06172088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06172088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study of Therapeutic Fasting to Reduce Limitations in Physical Well-being and Quality of Life During Endocrine Therapy With Aromatase Inhibitors
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2023
Completion date
September 30, 2025
Enrollment
54 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer patients treated with aromatase inhibitors